U.S. Auto Components Stock News

A surge of cargo is racing through West Coast ports ahead of a July 2026 tariff deadline, and that rush is quietly reshaping where money moves in the market. Companies tied to this import wave could see very different fortunes from those left on the sidelines, which creates a window you may not want to miss. This article walks through 3 stocks exposed to this trade shock and how each could be affected. Expeditors International of Washington (EXPD) Overview: Expeditors International of...

In the past quarter, Royal Gold, Inc. reported second-quarter 2026 sales of US$450.54 million and net income of US$236.39 million, with basic earnings per share from continuing operations rising to US$2.78. Over the first half of 2026, the company’s sales more than doubled to US$919.66 million and management issued full-year volume guidance across gold, silver, and copper, signaling confidence in its diversified metals portfolio. We’ll now examine how this sharp earnings growth and...

Arcutis Biotherapeutics, Inc. recently reported that chief commercial officer L. Todd Edwards will resign in August 2026, while also posting second-quarter 2026 revenue of US$129.86 million and net income of US$15.01 million and raising full-year 2026 net product sales guidance to US$525 million–US$540 million. An interesting aspect is that Arcutis is turning profitable and lifting its outlook at the same time it brings in seasoned commercial leader Robert Lisicki, whose prior experience...

Corcept Therapeutics stock has delivered a very large 5 year return, yet its recent valuation checks suggest the shares are not an obvious bargain at today's level. Over the past 5 years, Corcept Therapeutics has returned about 4.4x, which sets a high bar for any further upside to be justified by fundamentals. Investor focus is currently on how demand for the company’s treatments and late stage pipeline can support future revenue, while execution and clinical outcomes across those programs...

Trimble stock has delivered a decline of 34.2% over the past five years, yet the latest intrinsic value work using a Discounted Cash Flow (DCF) approach suggests the shares may still be trading at a sizeable discount to that estimate, even though market based multiples look roughly in line with peers. Over the last five years, Trimble has fallen 34.2%, which means long term holders have seen a material erosion in capital that puts extra focus on whether the current price offers a margin of...

Cirrus Logic reported past first-quarter fiscal 2027 results, with revenue rising to US$459.72 million and net income reaching US$76.85 million, alongside guidance for second-quarter revenue of US$510 million to US$570 million. The company paired record earnings with continued share repurchases and a US$467.57 million shelf registration tied to an ESOP offering, underscoring parallel commitments to capital returns and employee ownership. Next, we’ll examine how record earnings and stronger...

Honeywell International stock has delivered a 41.6% return over the past three years, and current valuation checks now suggest a mixed picture rather than a clear bargain or clear overvaluation. Over the last three years Honeywell International has returned 41.6%, which puts more focus on whether the present share price still leaves enough upside for new investors. Recent news around portfolio reshaping and a sharper focus on automation may support expectations for growth and cash...

Tesla stock sits at US$321.55 after a volatile spell, and the main question for investors is whether a company that has returned 36.3% over 5 years is now priced for too much optimism given how expensive it looks on broad valuation checks. Over the past 5 years Tesla has delivered a total return of 36.3%, which means long term holders have been rewarded even though shorter term moves have been choppy. Ambitious plans around Optimus humanoid robots and Full Self Driving can support high...

Carrier Global (CARR) raised its full year 2026 sales outlook to about US$23b after reporting second quarter results that combined higher revenue with lower net income compared with a year earlier. See our latest analysis for Carrier Global. Carrier Global's recent guidance increase and ongoing share buybacks come against a mixed market backdrop, with the stock delivering a 22.25% year to date share price return but only a 0.49% total shareholder return over the past year, suggesting momentum...

Blue Bird Corporation recently reported third-quarter 2026 results, with sales of US$517.16 million and net income of US$185.26 million, alongside updated full-year net revenue guidance of US$1.75 billion and a higher long-term profit outlook linked to its expanded Ford collaboration and Detroit Assembly Plant asset purchase. At the same time, Blue Bird agreed to take over design, manufacturing, and sales of Ford’s next-generation F-53/F-59 commercial stripped chassis, indicating a...

Tenable Holdings has delivered a 58.4% gain year to date, while the latest Discounted Cash Flow (DCF) intrinsic value estimate points to the shares trading around 12.9% below that model’s assessment of fair value. This sits against a broader valuation score that is still on the weak side. Year to date, Tenable Holdings is up 58.4%, which puts recent price action on the strong side and makes entry timing more important for valuation focused investors. Recent launches of AI focused cyber...

DoorDash (DASH) is back in focus after its second quarter earnings on 5 August 2026 showed revenue of US$4.45b and net income of US$200m, alongside continued investment in new delivery technologies. See our latest analysis for DoorDash. At a share price of US$207.27, DoorDash has seen a 1 month share price return of 9.98% and a 3 month share price return of 20.96%, even as the year to date share price return has declined 5.70%. Over a longer window, the 1 year total shareholder return has...

ZoomInfo Technologies (GTM) is back in focus after its second quarter 2026 earnings report showed a sharp swing from prior profitability to a US$643.7 million net loss, driven largely by a US$650.5 million goodwill impairment. See our latest analysis for ZoomInfo Technologies. Following the earnings release and goodwill impairment, ZoomInfo Technologies' share price has shown a short-term rebound, with a 7 day share price return of 10.24% and 30 day share price return of 22.41%. However,...

TOP Financial Group (TOP) has set a new direction after its Board approved a broad artificial intelligence expansion across its brokerage and trading operations, including dedicated infrastructure and potential technology acquisitions. See our latest analysis for TOP Financial Group. Against this AI expansion backdrop, TOP Financial Group’s share price has been volatile, with a 1-day share price return that fell 5.17% but a 90-day share price return of 169.68% and a 1-year total shareholder...

What Belden’s Latest Earnings and Guidance Tell Investors Belden (BDC) shares are in focus after the company released second quarter results showing higher sales and net income compared with a year earlier, along with updated third quarter revenue and earnings guidance. See our latest analysis for Belden. Belden’s latest earnings release and third quarter guidance have come alongside strong price momentum, with a 7 day share price return of 25.63% and a 1 year total shareholder return of...

Varonis Systems (VRNS) has put AI agent security in focus after launching Agent Intent-Based Access Control, or IBAC, in its Atlas platform, combining this product update with recent revenue guidance and earnings detail. See our latest analysis for Varonis Systems. The new AI security launch comes after a period of strong share price momentum for Varonis Systems, with a 90 day share price return of 51.32% and a year to date share price return of 35.46%, even though the 1 year total...

First Advantage (FA) drew investor focus on 6 August 2026 after reporting second quarter earnings, with sales of US$448.76 million and net income of US$16.91 million, alongside higher full year revenue guidance. See our latest analysis for First Advantage. At a share price of US$20.56, First Advantage has cooled slightly in the past week, although the 30.46% 90 day share price return and 26.84% 1 year total shareholder return still point to strong recent momentum that reflects shifting...

In late July 2026, Thermo Fisher Scientific highlighted a series of recent diagnostic product launches and FDA clearances at the ADLM conference in Anaheim, alongside strong second-quarter results with US$11.99 billion in sales and US$1.74 billion in net income. The combination of expanded specialty diagnostics offerings, such as the EXENT multiple myeloma platform and EliA CTD 13 autoimmune assay, and efficiency-focused tools like LabLink360 and InstaFlux underscores Thermo Fisher’s push to...

BILL Holdings has delivered a steep 76.4% share price decline over the past 5 years, yet its current valuation checks now suggest the stock screens on the cheap side. Recent short term gains raise a simple question for investors about whether that apparent discount still holds at today’s price. The share price has fallen 76.4% over 5 years, which puts the recent rebound into context as a recovery from a much lower base. For BILL Holdings, expectations around the durability of its growth and...

Sotera Health reported past second-quarter 2026 results showing revenue of US$321.38 million versus US$294.34 million a year earlier, with net income rising to US$53.64 million from US$7.96 million and diluted EPS from continuing operations increasing to US$0.19 from US$0.03. Over the first half of 2026, the company moved from a US$5.30 million net loss to US$80.23 million in net income, highlighting a sharp turnaround in profitability. We’ll now examine how this sharp swing from a prior...

Beam Therapeutics recently reported second-quarter 2026 results showing a wider net loss of US$122.68 million and a basic loss per share of US$1.18, alongside a sharp revenue shortfall versus analyst expectations. At the same time, the company marked important clinical milestones in its genome-editing pipeline, including completing dosing in its risto-cel sickle cell trial and dosing the first patient in the pivotal BEAM-302 study for alpha-1 antitrypsin deficiency. Now we’ll examine how the...

American Airlines Group (AAL) is back in focus after issuing fresh third quarter 2026 guidance and reporting mixed second quarter results, while options activity signals expectations of a sizeable share price move ahead. See our latest analysis for American Airlines Group. At a share price of $16.58, American Airlines Group has seen a 7 day share price return of 11.73% and a 90 day share price return of 25.80%. The 1 year total shareholder return of 41.23% contrasts with a 5 year total...

Airbnb (ABNB) is set to report its latest quarterly results after the closing bell on 6 August 2026. The stock is in focus as investors assess booking trends and travel demand. See our latest analysis for Airbnb. At a share price of US$152.49, Airbnb has logged a 30 day share price return of 3.28% and an 8.56% gain over 90 days. The 1 year total shareholder return of 16.85% and 5 year total shareholder return of 2.92% point to moderate long term progress as investors weigh growth prospects...

The Buckle, Inc. reported that for the 4-week, 13-week second quarter, and 26-week periods ended August 1, 2026, both comparable store net sales and total net sales increased, with quarterly net sales rising to US$319.8 million and year-to-date net sales reaching US$608.6 million. This consistent lift in same-store and total sales across short, quarterly, and half-year periods points to resilient customer demand and operational execution heading into the remainder of the fiscal year. Next,...